Latest return on equity
Avalo Therapeutics Return on equity
Direct answer
Avalo Therapeutics's return on equity is -36.27%.
The verified market snapshot reports -36.27%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -36.27%
Explore related company data
View Avalo Therapeutics's market capitalizationView Avalo Therapeutics's price-to-book ratioView Avalo Therapeutics's dividend yieldView Avalo Therapeutics's 52-week price rangeView Avalo Therapeutics's profit marginView Avalo Therapeutics's debt-to-equity ratioView all Avalo Therapeutics key metricsReturn to Avalo Therapeutics profile